Randomized clinical trial on the use of a colon-occlusion device to assist rectal washout

Transrectal Natural Orifice Transluminal Endoscopic Surgery is currently limited by the inherent risk of surgical site infection due to peritoneal contamination after rectotomy. Coloshield has been developed as a temporary colon occlusion device to facilitate rectal washout. However, effectiveness a...

Full description

Saved in:
Bibliographic Details
Main Authors: Cordewener, Carolin (Author) , Zürcher, Manuel (Author) , Müller, Philip C. (Author) , Müller, Beat P. (Author) , Zerz, Andreas (Author) , Linke, Georg R. (Author) , Steinemann, Daniel (Author)
Format: Article (Journal)
Language:English
Published: September 2021
In: Surgical endoscopy
Year: 2021, Volume: 35, Issue: 9, Pages: 5078-5087
DOI:10.1007/s00464-020-07992-9
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00464-020-07992-9
Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s00464-020-07992-9
Get full text
Author Notes:Carolin Cordewener, Manuel Zürcher, Philip C. Müller, Beat P. Müller-Stich, Andreas Zerz, Georg R. Linke, Daniel C. Steinemann
Description
Summary:Transrectal Natural Orifice Transluminal Endoscopic Surgery is currently limited by the inherent risk of surgical site infection due to peritoneal contamination after rectotomy. Coloshield has been developed as a temporary colon occlusion device to facilitate rectal washout. However, effectiveness and safety has not been evaluated in humans.
Item Description:Online publiziert: 23. September 2020
Gesehen am 05.09.2021
Physical Description:Online Resource
DOI:10.1007/s00464-020-07992-9